Shopping Cart

No products in the cart.

ISO 18362:2016

$41.60

Manufacture of cell-based health care products — Control of microbial risks during processing

Published By Publication Date Number of Pages
ISO 2016-02 42
Guaranteed Safe Checkout
Categories: ,

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

ISO 18362:2016 specifies the minimum requirements for, and provides guidance on, a risk-based approach for the processing of cell-based health care products (CBHPs) requiring control of viable and non-viable microbial contamination. It is applicable both to CBHPs labelled 'sterile' and to CBHPs not labelled 'sterile'.

ISO 18362:2016 is not applicable to:

– procurement and transport of cell-based starting material used in processing of a CBHP,

– cell banking,

– control of genetic material,

– control of non-microbial product contamination,

in vitro diagnostics (IVDs), or

– natural medicines.

EXAMPLE Vitamins and minerals, herbal remedies, homoeopathic medicines, traditional medicines such as traditional Chinese medicines, probiotics, other products such as amino acids and essential fatty acids.

ISO 18362:2016 does not define biosafety containment requirements.

ISO 18362:2016 does not replace national or regional regulations that apply to the manufacture and quality control of a CBHP.

ISO 18362:2016
$41.60